How do I select cerebral protection devices today?

Journal of Cardiovascular Surgery

Volumn 51, Issue 6, 2010, Pages 873-883

  Schneider, P A ^a   Ansel, G ^a  

^a Hawaii Permanante Medical Group   (United States)

Author keywords

Atherosclerosis; Brain; Embolization, therapeutic

Indexed keywords

ATHEROSCLEROSIS; BRAIN PROTECTION; CAROTID ARTERY; CLINICAL PRACTICE; FILTER; HUMAN; MEDICAL INSTRUMENTATION; REVIEW; RISK FACTOR; STENT;

ANGIOPLASTY; CAROTID ARTERY DISEASES; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COLLATERAL CIRCULATION; EMBOLIC PROTECTION DEVICES; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; STENTS; TREATMENT OUTCOME;

EID: 79952054214     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Kastrup A, Gröschel K, Krapf H, Brehm BR, Dichgans J, Schulz JB. Stroke 2003;34:813-19.
2. Macdonald S, Evans DH, Griffiths PD, McKevitt FM, Venables GS, Cleveland TJ et al. Filter-protected versus unprotected carotid artery stenting: a randomised trial. Cerebrovasc Dis 2010;29:282-9.
3. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W et al. CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11-23.
4. International Carotid Stenting Study investigators, Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010;375:985-97.
5. Ansel GM, Hopkins LN, Jaff MR, Rubino P, Bacharach JM, Scheinen D et al. Investigators for the ARMOUR Pivotal Trial. Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv 2010;76:1-8.
6. Embolic protection with reversed flow (EMPIRE). ClinicalTrials. gov
7. Abbott. Homepage [Internet]. Available from www.abbott.com [cited 2010, Oct 12].
8. Boston Scientific. Homepage. [Internet]. Available from www.bostonscientific.com [cited 2010, Oct 12].
9. EV3. Homepage [Internet]. Available from www.ev3. net [cited 2010, Oct 12].
10. Cordis. Homepage [Internet]. Available from www.cordis.com [cited 2010, Oct 12].
11. Medtronic. Homepage [Internet]. Available from www.medtronic.com [cited 2010, Oct 12].
12. Medtronic Invatec. Homepage. [Internet]. Available from www.invatec.com [cited 2010, Oct 12].
13. Gore. Homepage [Internet]. Available from www.goremedical. com [cited 2010, Oct 12].
14. Garami ZF, Bismuth J, Charlton-Ouw KM, Davies MG, Peden EK, Lumsden AB. Feasibility of simultaneous pre- and postfilter transcranial Doppler monitoring during carotid artery stenting. J Vasc Surg 2009;49:340-4.
15. Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J, Nederkoorn PJ et al. ICSS-MRI study group. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol 2010;9:353-62.
16. Schnaudigel S, Gröschel K, Pilgram SM, Kastrup A. New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature. Stroke 2008;39:1911-9.
17. Asakura F, Kawaguchi K, Sakaida H, Toma N, Matsushima S, Kuraishi K et al. Diffusion-weighted MR imaging in carotid angioplasty and stenting with protection by the reversed carotid arterial flow. AJNR Am J Neuroradiol 2006;27:753-8. (Pubitemid 44897717)
18. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-501.
19. The SPACE Collaborative Group. 30-day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomized inferiority trial. Lancet 2006;368:1239-47.
20. Stingele R, Berger J, Alfke K et al. Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol 2008;7:216-22.
21. Mas J-L, Chatellier G, Beyssen B, Eckstein HH, Fraedrich G, Allenberg J et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660-71. (Pubitemid 44583956)
22. Mansour MA. Carotid artery stenting in the SPACE and EVA-3S trials: analysis and update. Perspect Vasc Surg Endovasc Ther 2008;20:11-4.
23. Mas JL, Chatellier G, Beyssen Bl EVA-3S Investigators. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke 2004;35: e18-20.
24. Palombo G, Stella N, Faraglia V, Rizzo L, Fantozzi C, Bozzao A et al. Cervical access for filter-protected carotid artery stenting: a useful tool to reduce cerebral embolisation. Eur J Vasc Endovasc Surg 2010;39:252-7.
25. Leal JI, Orgaz A, Fontcuberta J, Flores A, Doblas M, Garcia-Benassi JM et al. A prospective evaluation of cerebral infarction following transcervical carotid stenting with carotid flow reversal. Eur J Vasc Endovasc Surg 2010;39:661-6.
26. Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, Dempsey RJ et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1998;97:501-9. (Pubitemid 28090224)
27. Hobson RW, Howard VJ, Roubin GS, Brott TG, Ferguson RD, Popma JJ et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST. J Vasc Surg 2004;40:1106-11. (Pubitemid 40044678)
28. Stanziale SF, Marone LK, Boules TN, Brimmeier JA, Hill K, Makaroun MS et al. Carotid artery stenting in octogenarians is associated with increased adverse outcomes. J Vasc Surg 2006;43:297-304. (Pubitemid 43221924)
29. Lin SC, Trocciola SM, Rhee J, Dayal R, Chaer R, Morrissey NJ et al. Analysis of anatomic factors and age in patients undergoing carotid angioplasty and stenting. Ann Vasc Surg 2005;19:798-804.
30. Lam RC, Lin SC, DeRubertis B, Hynecek R, Kent KC, Faries PL. The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. J Vasc Surg 2007;45.875-80.
31. Kastrup A, Gröschel K, Schnaudigel S, Nägele T, Schmidt F, Ernemann U. Target lesion ulceration and arch calcification are associated with increased incidence of carotid stenting-associated ischemic lesions in octogenarians. J Vasc Surg 2008;47:88-95.
32. Faggioli GL, Ferri M, Freyrie A, Gargiulo M, Fratesi F, Rossi C et al. Aortic arch anomalies are associated with increased risk of neurological events in carotid stent procedures. Eur J Vasc Endovasc Surg 2007;33:436-41. (Pubitemid 46336601)
33. Faggioli GL, Ferri M, Gargiulo M, Freyrie A, Fratesi F, Manzoli L et al. Measurement and impact of proximal and distal tortuosity in carotid stenting procedures. J Vasc Surg 2007;46:1119-24. (Pubitemid 350267080)
34. Sayeed S, Stanziale SF, Wholey MH, Makaroun MS. Angiographic lesion characteristics can predict adverse outcomes after carotid artery stenting. J Vasc Surg 2008;47:81-7.
35. Biasi GM, Froio A, Diethrich EB et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) Study. Circulation 2004;110:756-62. (Pubitemid 39056278)